Oracle Prices $20 Bln Stock And Notes Offering At $116/Shr

What happened

Oracle priced concurrent public offerings of stock and senior notes totaling $20 billion. The stock offering is 86.2 million shares at $116 per share, with net proceeds of about $9.9 billion, while the notes offering is $10 billion of senior notes. Both are expected to close November 4.

Confirmed

Global impact / market context

Selling new shares increases Oracle's share count, which can spread future profit across more owners and dilute each existing share's claim. Borrowing $10 billion adds interest costs, but the combined cash gives Oracle more money for capital spending, which means long-term investments like data centers and equipment.

Analyst inference

The stock closed down 8.76% at $119.22 on the New York Stock Exchange, below the $116 offer price, suggesting selling pressure as investors absorbed dilution, which means the reduction in each existing share's claim from 86.2 million new shares. Overnight trading edged 0.23% higher to $119.51.

Analyst inference

What to watch

1. Both offerings are expected to close on November 4, so investors should confirm completion and final net proceeds before the capital-raising is treated as settled. Confirmed
2. Oracle proposes to use net proceeds for general corporate purposes, including capital spending, debt repayment, future investments or acquisitions, and cash dividends or stock repurchases. Proposed
3. Watch Oracle's interest costs from the senior notes, which are borrowed money, and any share count rise from the 86.2 million shares, since debt repayments or buybacks could partly offset that dilution, which means the reduction in each share's claim. Analyst inference

Evidence

• Original source link unavailable